Table 1.
Protein* | Exposed surface area of mutated residue in the native state (Å2)† | Percent area of mutated residue exposed in the native state† | Stability in bulk solution (kcal mol−1) | Change in stability in bulk solution upon mutation (kcal mol−1)‡ | Stability in the cavity (kcal mol−1) | Change in stability in the cavity upon mutation (kcal mol−1)‡ |
---|---|---|---|---|---|---|
WT in GroE§ | - | - | −3.45 ± 0.09 | - | 2.4 ± 0.2 | - |
WT in (αβ)4 | - | - | −3.45 ± 0.09 | - | 2.7 ± 0.3 | - |
WT in β9 | - | - | −3.45 ± 0.09 | - | 3.3 ± 0.2 | - |
L9V in GroE | 4.0 | 3.5 | −2.60 ± 0.13 | 0.85 ± 0.15 | 3.7 ± 0.3 | 1.3 ± 0.4 |
I41V in GroE | 0.0 | 0 | −2.95 ± 0.07 | 0.50 ± 0.11 | 1.6 ± 0.1 | −0.8 ± 0.2 |
I61V in GroE | 0.1 | 0 | −3.16 ± 0.07 | 0.29 ± 0.11 | 2.2 ± 0.2 | −0.2 ± 0.3 |
L93V in GroE | 5.4 | 4.0 | −1.52 ± 0.18 | 1.93 ± 0.20 | 0.9 ± 0.1 | −1.5 ± 0.2 |
I95V in GroE | 5.8 | 3.5 | −3.03 ± 0.09 | 0.42 ± 0.13 | 2.8 ± 0.3 | 0.4 ± 0.4 |
*Single-letter notation of amino acids is used.
†Values represent averages for the two dihydrofolate reductase chains (A and B) related by noncrystallographic symmetry in the crystal structure (PDB ID: 2zza). The solvent-accessible surface areas for each residue listed were calculated using PyMOL.
‡The changes in stability in bulk solution and in the cavity upon mutation were calculated as: ∆G(mutant) – ∆G(wild-type).
§The data for wild-type DHFRMp in the chimera were reported before (23).